USD 0.0
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2019 | - USD | 0.0% |
2015 | 5.69 Million USD | -38.09% |
2014 | 9.19 Million USD | -46.11% |
2013 | 17.05 Million USD | 0.32% |
2012 | 17 Million USD | -8.09% |
2011 | 18.5 Million USD | 26.37% |
2010 | 14.63 Million USD | -8.77% |
2009 | 16.04 Million USD | 41.6% |
2008 | 11.33 Million USD | 0.0% |
2006 | 10.23 Million USD | 10.85% |
2005 | 9.23 Million USD | -16.5% |
2004 | 11.06 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2022 FY | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2015 FY | 5.69 Million USD | -38.09% |
2015 Q3 | 1.25 Million USD | -29.3% |
2015 Q4 | 1.11 Million USD | -11.69% |
2015 Q1 | 1.54 Million USD | -1.84% |
2015 Q2 | 1.77 Million USD | 15.16% |
2014 Q1 | 2.43 Million USD | -2.48% |
2014 FY | 9.19 Million USD | -46.11% |
2014 Q3 | 2.69 Million USD | 8.24% |
2014 Q4 | 1.57 Million USD | -41.61% |
2014 Q2 | 2.48 Million USD | 2.09% |
2013 Q3 | 4.04 Million USD | -21.65% |
2013 FY | 17.05 Million USD | 0.32% |
2013 Q2 | 5.16 Million USD | -3.24% |
2013 Q1 | 5.34 Million USD | 52.47% |
2013 Q4 | 2.5 Million USD | -38.26% |
2012 Q3 | 6.93 Million USD | 7.43% |
2012 Q2 | 6.45 Million USD | -16.89% |
2012 Q1 | 7.76 Million USD | 57.81% |
2012 FY | 17 Million USD | -8.09% |
2012 Q4 | 3.5 Million USD | -49.5% |
2011 Q4 | 4.92 Million USD | -1.7% |
2011 Q1 | 3.7 Million USD | 31.25% |
2011 Q2 | 4.86 Million USD | 31.59% |
2011 FY | 18.5 Million USD | 26.37% |
2011 Q3 | 5 Million USD | 2.85% |
2010 Q4 | 2.81 Million USD | -19.09% |
2010 FY | 14.63 Million USD | -8.77% |
2010 Q3 | 3.48 Million USD | -1.8% |
2010 Q2 | 3.54 Million USD | -25.9% |
2010 Q1 | 4.78 Million USD | 19.58% |
2009 Q4 | 4 Million USD | -9.74% |
2009 FY | 16.04 Million USD | 41.6% |
2009 Q3 | 4.43 Million USD | 0.0% |
2008 FY | 11.33 Million USD | 0.0% |
2007 Q3 | 4.88 Million USD | 23.34% |
2007 Q2 | 3.96 Million USD | 13.88% |
2007 Q1 | 3.48 Million USD | 29.37% |
2006 FY | 10.23 Million USD | 10.85% |
2006 Q3 | 2.62 Million USD | 2.18% |
2006 Q1 | 2.35 Million USD | 0.0% |
2006 Q2 | 2.56 Million USD | 8.86% |
2006 Q4 | 2.69 Million USD | 2.55% |
2005 FY | 9.23 Million USD | -16.5% |
2004 FY | 11.06 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
American Medical Technologies Inc. | 2.86 Million USD | 100.0% |
Ansell Limited | 495.5 Million USD | 100.0% |
Ansell Limited | 495.5 Million USD | 100.0% |
Biotage AB (publ) | 82.8 Million USD | 100.0% |
BioLife Sciences Inc. | - USD | NaN% |
CB Scientific, Inc. | 1.73 Million USD | 100.0% |
Psykey, Inc. | 1.21 Million USD | 100.0% |
ConvaTec Group Plc | 910.31 Million USD | 100.0% |
ConvaTec Group Plc | 872.5 Million USD | 100.0% |
Encision Inc. | 3.77 Million USD | 100.0% |
Golden Valley Development, Inc | 141.81 Thousand USD | 100.0% |
Hear AtLast Holdings, Inc. | 109.93 Thousand USD | 100.0% |
Innovative MedTech Inc. | 6.09 Million USD | 100.0% |
LifePoint, Inc. | 7.42 Million USD | 100.0% |
Medite Cancer Diagnostics, Inc. | 6.34 Million USD | 100.0% |
Paradigm Medical Industries, Inc. | 855 Thousand USD | 100.0% |
QuantRx Biomedical Corporation | - USD | NaN% |
Remedent, Inc. | 726.13 Thousand USD | 100.0% |
Reflect Scientific, Inc. | 1.06 Million USD | 100.0% |
SmileDirectClub, Inc. | 517 Million USD | 100.0% |
Sector 10, Inc. | 39.84 Thousand USD | 100.0% |
Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 100.0% |
SheerVision, Inc. | 2.33 Million USD | 100.0% |
United Health Products, Inc. | 2.42 Million USD | 100.0% |
Vasamed, Inc. | 4.67 Million USD | 100.0% |
Wearable Health Solutions, Inc. | 2.56 Million USD | 100.0% |
Yubo International Biotech Limited | 1.25 Million USD | 100.0% |